RESUMEN
BACKGROUND: Evaluation of the boron dose is essential for boron neutron capture therapy (BNCT). Nevertheless, a direct evaluation method for the boron-dose distribution has not yet been established in the clinical BNCT field. To date, even in quality assurance (QA) measurements, the boron dose has been indirectly evaluated from the thermal neutron flux measured using the activation method with gold foil or wire and an assumed boron concentration in the QA procedure. Recently, we successfully conducted optical imaging of the boron-dose distribution using a cooled charge-coupled device (CCD) camera and a boron-added liquid scintillator at the E-3 port facility of the Kyoto University Research Reactor (KUR), which supplies an almost pure thermal neutron beam with very low gamma-ray contamination. However, in a clinical accelerator-based BNCT facility, there is a concern that the boron-dose distribution may not be accurately extracted because the unwanted luminescence intensity, which is irrelevant to the boron dose is expected to increase owing to the contamination of fast neutrons and gamma rays. PURPOSE: The purpose of this research was to study the validity of a newly proposed method using a boron-added liquid scintillator and a cooled CCD camera to directly observe the boron-dose distribution in a clinical accelerator-based BNCT field. METHOD: A liquid scintillator phantom with 10 B was prepared by filling a small quartz glass container with a commercial liquid scintillator and boron-containing material (trimethyl borate); its natural boron concentration was 1 wt%. Luminescence images of the boron-neutron capture reaction were obtained in a water tank at several different depths using a CCD camera. The contribution of background luminescence, mainly due to gamma rays, was removed by subtracting the luminescence images obtained using another sole liquid scintillator phantom (natural boron concentration of 0 wt%) at each corresponding depth, and a depth profile of the boron dose with several discrete points was obtained. The obtained depth profile was compared with that of calculated boron dose, and those of thermal neutron flux which were experimentally measured or calculated using a Monte Carlo code. RESULTS: The depth profile evaluated from the subtracted images indicated reasonable agreement with the calculated boron-dose profile and thermal neutron flux profiles, except for the shallow region. This discrepancy is thought to be due to the contribution of light reflected from the tank wall. The simulation results also demonstrated that the thermal neutron flux would be severely perturbed by the 10 B-containing phantom if a relatively larger container was used to evaluate a wide range of boron-dose distributions in a single shot. This indicates a trade-off between the luminescence intensity of the 10 B-added phantom and its perturbation effect on the thermal neutron flux. CONCLUSIONS: Although a partial discrepancy was observed, the validity of the newly proposed boron-dose evaluation method using liquid-scintillator phantoms with and without 10 B was experimentally confirmed in the neutron field of an accelerator-based clinical BNCT facility. However, this study has some limitations, including the trade-off problem stated above. Therefore, further studies are required to address these limitations.
Asunto(s)
Terapia por Captura de Neutrón de Boro , Boro , Humanos , Terapia por Captura de Neutrón de Boro/métodos , Estudios de Factibilidad , Neutrones , Fantasmas de Imagen , Método de Montecarlo , Imagen Óptica , Dosificación RadioterapéuticaRESUMEN
10B-neutron capture was observed optically using a boron-added liquid scintillator. Trimethyl borate was dissolved in a commercially available liquid scintillator at natural boron concentrations of approximately 1 wt% and 0.25 wt%. The boron-added liquid scintillator was placed in a phantom quartz bottle and irradiated by thermal neutrons (~ 105 n/[cm2 s]) for 150, 300, and 600 s. The luminescence of the liquid scintillator was clearly observed using a cooled charge-coupled device (CCD) camera during irradiation. The luminance value recorded by the CCD camera was proportional to the duration of irradiation by thermal neutrons. The luminescence distribution showed reasonable agreement with that of energy deposition by Li and alpha particles from 10B-neutron capture reactions calculated via Monte Carlo simulations. When trimethyl borate was not dissolved in the liquid scintillator (0 wt% natural boron), no visible luminescence was observed even after 600 s of irradiation. These findings demonstrate that the observed luminance originates from the Li and alpha particles generated by 10B-neutron capture reactions. Consequently, the luminescence distribution is directly related to the boron dose of the liquid scintillator. To the best of our knowledge, direct experimental optical observations of boron dose distribution have not yet been reported. This novel technique will be useful for quality assurance in boron neutron capture therapy (BNCT) because instantaneous neutron irradiation may be sufficient for the observing the intense neutron beam used in clinical BNCT (~ 109 n/[cm2 s]), and quick evaluation of the boron dose distribution is expected to be feasible.